Alternative names: |
(2b,3b,4b,5a,12b,19a)-4-(Acetyloxy)-6,7-didehydro-15-[(2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methylaspidospermidine-3-carboxylic Acid Methyl Ester (2R,3R)-2,3-Dihydroxybutanedioate; 4'-Deoxy-20',20'-difluoro-5'-nor-
vincaleukoblastine Ditartrate; 20',20'-Difluoro-3',4'-dihydrovinorelbine Ditartrate; BMS 710485; F 12158; Javlor; |
References: |
Kruczynski, A., et al.: Crit. Rev. Oncol. Hematol., 40, 159 (2001), Fabre, C., et al.: Biochem. Pharmacol., 64, 733 (2002), Bennouna, J. et al.: Ann. Oncol., 14, 630 (2003), Bennouna, J., et al.: Expert Opin. Invest. Drugs, 14, 1259 (2005). |